ArticleBMC rheumatology2026
Carpal tunnel syndrome in systemic sclerosis: prevalence, clinical correlates, and diagnostic performance of ultrasound compared with nerve conduction studies.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCarpal tunnel syndrome (CTS) is a frequent yet under-recognized complication in systemic sclerosis (SSc), where hand symptoms may overlap with vasculopathy and musculoskeletal involvement. Consequently, diagnosis often requires nerve conduction studies (NCS), while the role of ultrasound remains incompletely defined. We aimed to determine the prevalence of CTS in SSc using NCS as the reference standard, identify associated clinical and disease-related factors, and assess the diagnostic performance of ultrasound.
methodsWe conducted a cross-sectional study including consecutive SSc patients recruited from the Rheumatology Unit of Colentina Clinical Hospital, Bucharest, Romania (January 2023-March 2025). All participants underwent standardized clinical examination, comprehensive musculoskeletal ultrasound, and NCS within a 7-day interval. The ultrasound protocol incorporated multiple structural and dynamic parameters of the median nerve, including maximal cross-sectional area (maxCSA) and complementary measurements. CTS was defined and staged electrophysiologically according to the Bland scale. Associations were analyzed using clustered generalized estimating equation models accounting for bilateral hands. Ultrasound diagnostic performance was evaluated using maxCSA thresholds and receiver operating characteristic analysis.
resultsThe study included 109 patients (218 hands). NCS-defined CTS was present in 34.1% of hands and in 44.0% of patients, indicating a substantial burden of objective neuropathy in SSc. Independent associations were predominantly traditional vascular and occupational factors, particularly arterial hypertension and smoking, whereas global SSc phenotype variables were not independently associated. Median nerve maxCSA showed moderate discriminative ability (AUC 0.722) with an optimal cutoff of 10 mm². Threshold-based definitions demonstrated increasing specificity with higher cutoffs. Although sensitivity remained limited, a positive ultrasound was substantially associated with the presence of CTS.
conclusionsCTS is common in SSc when systematically investigated and appears to be associated with general vascular vulnerability than with global disease phenotype. Ultrasound provides clinically meaningful complementary information, particularly as a confirmation and triage tool, and performs best in more advanced disease. While NCS remains important for exclusion and severity staging, ultrasound may help triage and support diagnosis in selected high-probability cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.